ZBIO
Zenas BioPharma Inc.
$35.80
+$0.96(+2.76%)
60
Overall
55
Value
66
Tech
--
Quality
Market Cap
$1.94B
Volume
240.15K
52W Range
$5.83 - $38.50
Target Price
$43.57
Order:
Income Statement
| Metric | Trend | Chart | 2023 Dec | 2024 Dec |
|---|---|---|---|---|
| REVENUE | ||||
| Total Revenue | $50.0M | $5.0M | ||
| Total Revenue | $50.0M | $5.0M | ||
| GROSS PROFIT | ||||
| Gross Profit | $50.0M | $5.0M | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $87.1M | $168.9M | ||
| Research & Development | $70.0M | $139.1M | ||
| Research Expense | $70.0M | $139.1M | ||
| Selling, General & Administrative | $17.1M | $29.7M | ||
| General & Administrative Expenses | $17.1M | $29.7M | ||
| OPERATING INCOME | ||||
| Operating income | $-37.1M | $-163.9M | ||
| EBITDA | $-36.7M | $-156.4M | ||
| NON-OPERATING ITEMS | ||||
| Other Income/Expense | $-324.0K | $-8.2M | ||
| Other Special Charges | $324.0K | $8.2M | ||
| PRE-TAX INCOME | ||||
| EBIT | $-36.8M | $-156.6M | ||
| Pre-Tax Income | $-36.8M | $-156.6M | ||
| INCOME TAX | ||||
| Tax Provision | $301.0K | $429.0K | ||
| NET INCOME | ||||
| Net Income | $-37.1M | $-157.0M | ||
| Net Income (Continuing Operations) | $-37.1M | $-157.0M | ||
| Net Income (Discontinued Operations) | $-37.1M | $-157.0M | ||
| Net Income (Common Stockholders) | $-37.1M | $-157.0M | ||
| Normalized Income | $-27.1M | $-155.0M | ||
| TOTALS | ||||
| Total Expenses | $87.1M | $168.9M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $13.3M | $13.2M | ||
| Average Shares Outstanding (Diluted) | $13.3M | $13.2M | ||
| Shares Outstanding | $42.1M | $41.8M | ||
| Basic EPS | -- | $-11.89 | ||
| Basic EPS (Continuing Operations) | -- | $-11.89 | ||
| Diluted EPS | -- | $-11.89 | ||
| Diluted EPS (Continuing Operations) | -- | $-11.89 | ||
| OTHER METRICS | ||||
| Other Gand A | $17.1M | $29.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZBIO | $35.80 | +2.8% | 240.15K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |